このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Cryoport 過去の業績
過去 基準チェック /06
Cryoportの収益は年間平均-27.7%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間16.8% 37.3%割合で 増加しています。
主要情報
-27.7%
収益成長率
-23.7%
EPS成長率
Life Sciences 業界の成長 | 21.5% |
収益成長率 | 37.3% |
株主資本利益率 | -23.9% |
ネット・マージン | -53.7% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch
Jun 25Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Cryoport: An Industry Leader Basking In Industry Tailwinds
Apr 15Cryoport: Risky Investment With Upside Potential
Apr 01Cryoport: More Growth Going Into New Year 2022
Dec 29Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 49% Discount?
Dec 05What Is Cryoport, Inc.'s (NASDAQ:CYRX) Share Price Doing?
Nov 09Is Cryoport (NASDAQ:CYRX) Using Too Much Debt?
Oct 17Cryoport: The Golden Stock
Oct 08Cryoport: Unfairly Punished, Valuation Update Shows 45% Upside
Oct 01Cryoport: Best Price-Positioned Medical Services Stock, As Seen By Market-Makers
Jul 01収支内訳
収支内訳
Cryoport の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 225 | -121 | 145 | 19 |
31 Dec 23 | 233 | -108 | 140 | 18 |
30 Sep 23 | 236 | -55 | 134 | 18 |
30 Jun 23 | 241 | -47 | 128 | 17 |
31 Mar 23 | 248 | -38 | 125 | 16 |
31 Dec 22 | 237 | -45 | 118 | 16 |
30 Sep 22 | 233 | -296 | 109 | 15 |
30 Jun 22 | 230 | -297 | 103 | 15 |
31 Mar 22 | 222 | -293 | 98 | 16 |
31 Dec 21 | 223 | -284 | 98 | 17 |
30 Sep 21 | 215 | -76 | 93 | 16 |
30 Jun 21 | 169 | -78 | 77 | 15 |
31 Mar 21 | 122 | -77 | 61 | 12 |
31 Dec 20 | 79 | -75 | 47 | 9 |
30 Sep 20 | 40 | -22 | 28 | 7 |
30 Jun 20 | 38 | -23 | 36 | 6 |
31 Mar 20 | 37 | -20 | 33 | 5 |
31 Dec 19 | 34 | -18 | 31 | 4 |
30 Sep 19 | 30 | -20 | 31 | 3 |
30 Jun 19 | 26 | -9 | 20 | 2 |
31 Mar 19 | 22 | -9 | 18 | 2 |
31 Dec 18 | 20 | -10 | 17 | 2 |
30 Sep 18 | 17 | -10 | 16 | 2 |
30 Jun 18 | 15 | -9 | 15 | 2 |
31 Mar 18 | 13 | -9 | 14 | 1 |
31 Dec 17 | 12 | -8 | 13 | 1 |
30 Sep 17 | 11 | -10 | 12 | 1 |
30 Jun 17 | 10 | -10 | 11 | 1 |
31 Mar 17 | 9 | -12 | 11 | 1 |
31 Dec 16 | 8 | -13 | 11 | 1 |
30 Sep 16 | 7 | -12 | 11 | 1 |
30 Jun 16 | 6 | -12 | 11 | 1 |
31 Mar 16 | 6 | -15 | 10 | 0 |
31 Dec 15 | 6 | -16 | 9 | 0 |
30 Sep 15 | 5 | -15 | 8 | 0 |
30 Jun 15 | 4 | -16 | 7 | 0 |
31 Mar 15 | 4 | -12 | 6 | 0 |
31 Dec 14 | 4 | -10 | 6 | 0 |
30 Sep 14 | 3 | -10 | 6 | 0 |
30 Jun 14 | 3 | -21 | 5 | 0 |
31 Mar 14 | 3 | -20 | 5 | 0 |
31 Dec 13 | 2 | -20 | 5 | 0 |
30 Sep 13 | 2 | -20 | 5 | 0 |
質の高い収益: CYRXは現在利益が出ていません。
利益率の向上: CYRXは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: CYRXは利益が出ておらず、過去 5 年間で損失は年間27.7%の割合で増加しています。
成長の加速: CYRXの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: CYRXは利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -6.5% ) と比較することは困難です。
株主資本利益率
高いROE: CYRXは現在利益が出ていないため、自己資本利益率 ( -23.91% ) はマイナスです。